Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Challenges and future prospects in gene therapy.

Byrnes AP.

IDrugs. 2005 Dec;8(12):993-6.

PMID:
16320132
2.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
3.

Cancer gene therapy: challenges and opportunities.

Scanlon KJ.

Anticancer Res. 2004 Mar-Apr;24(2A):501-4. Review.

4.

Prospects for gene therapy in lung disease.

Davies JC, Geddes DM, Alton EW.

Curr Opin Pharmacol. 2001 Jun;1(3):272-7. Review.

PMID:
11712751
5.

[Prospects of gene therapy].

BaraƄska M, Skretkowicz J.

Wiad Lek. 2007;60(7-8):305-11. Review. Polish.

PMID:
18175548
6.
7.

Gene therapy of cancer in the clinic: good news in sight from Asia?

Favaro E, Indraccolo S.

Curr Opin Mol Ther. 2007 Oct;9(5):477-82. Review.

PMID:
17932811
8.

Cancer gene therapy with targeted adenoviruses.

Bachtarzi H, Stevenson M, Fisher K.

Expert Opin Drug Deliv. 2008 Nov;5(11):1231-40. doi: 10.1517/17425240802507636 . Review.

PMID:
18976133
9.

Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies.

Ohlfest JR, Freese AB, Largaespada DA.

Curr Gene Ther. 2005 Dec;5(6):629-41. Review.

PMID:
16457652
10.

Gene therapy in prostate cancer: past, present and future.

Shirakawa T, Fujisawa M, Gotoh A.

Front Biosci. 2008 Jan 1;13:2115-9. Review.

PMID:
17981696
11.

Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.

Li SD, Huang L.

Gene Ther. 2006 Sep;13(18):1313-9. Review.

PMID:
16953249
12.

Gene therapy progress and prospects: the skin--easily accessible, but still far away.

Hengge UR.

Gene Ther. 2006 Nov;13(22):1555-63. Epub 2006 Sep 7. Review.

PMID:
16957767
13.

Current prospects for gene therapy of cystic fibrosis.

Ziady AG, Davis PB.

Curr Opin Pharmacol. 2006 Oct;6(5):515-21. Epub 2006 Aug 4. Review.

PMID:
16890018
14.

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP.

Biomaterials. 2008 Aug-Sep;29(24-25):3477-96. doi: 10.1016/j.biomaterials.2008.04.036. Epub 2008 May 21. Review.

15.

Non-viral vectors for cancer therapy.

Kaneda Y, Tabata Y.

Cancer Sci. 2006 May;97(5):348-54. Review.

16.

Gene therapy progress and prospects cancer: oncolytic viruses.

Liu TC, Kirn D.

Gene Ther. 2008 Jun;15(12):877-84. doi: 10.1038/gt.2008.72. Epub 2008 Apr 17. Review.

PMID:
18418413
17.

rAAV vector-mediated gene therapy for experimental ischemic stroke.

Li ZJ, Wang RZ.

Neurol India. 2008 Apr-Jun;56(2):116-21. Review.

18.

Cancer gene therapy using adeno-associated virus vectors.

Park K, Kim WJ, Cho YH, Lee YI, Lee H, Jeong S, Cho ES, Chang SI, Moon SK, Kang BS, Kim YJ, Cho SH.

Front Biosci. 2008 Jan 1;13:2653-9. Review.

PMID:
17981740
19.

Gene therapy for pain.

Jain KK.

Expert Opin Biol Ther. 2008 Dec;8(12):1855-66. doi: 10.1517/14712590802496977 . Review.

PMID:
18990073
20.

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.

Pringle IA, Hyde SC, Gill DR.

Expert Opin Biol Ther. 2009 Aug;9(8):991-1003. doi: 10.1517/14712590903055029. Review.

PMID:
19545217

Supplemental Content

Support Center